Carcinogenic Etheno DNA Adducts in Alcoholic Liver Disease: Correlation with Cytochrome P‐4502E1 and Fibrosis

BACKGROUND One mechanism by which alcoholic liver disease (ALD) progresses is oxidative stress and the generation of reactive oxygen species, among others due to the induction of cytochrome P-4502E1 (CYP2E1). Experimental data underline the key role of CYP2E1 because ALD could be partially prevented in rats by the administration of the specific CYP2E1 inhibitor chlormethiazole. As CYP2E1 is linked to the formation of carcinogenic etheno DNA adducts in ALD patients, a causal role of alcohol-induced CYP2E1 in hepatocarcinogenesis is implicated. The purpose of this study was to investigate CYP2E1 induction in ALD, and its correlation with oxidative DNA lesions and with hepatic histology. METHODS Hepatic biopsies from 97 patients diagnosed with ALD were histologically scored for steatosis, inflammation, and fibrosis. CYP2E1 and the exocyclic etheno DNA adduct 1,N6 -etheno-2'deoxyadenosine (εdA) were determined immunohistochemically. In addition, in 42 patients, 8-hydroxydeoxyguanosine (8-OHdG) was also evaluated using immunohistochemistry. RESULTS A significant positive correlation was found between CYP2E1 and εdA (p < 0.0001) as well as between CYP2E1 and 8-OHdG (p = 0.039). Both CYP2E1 (p = 0.0094) and ɛdA (p < 0.0001) also correlated significantly with the stage of hepatic fibrosis. Furthermore, a significant correlation between the fibrosis stage and the grade of lobular inflammation (p < 0.0001) was observed. However, the amount of alcohol consumed did not correlate with any of the parameters determined. CONCLUSIONS These data suggest an important role of CYP2E1 in the generation of εdA, in the fibrotic progression of ALD, and thus in alcohol-mediated hepatocarcinogenesis. CYP2E1 may be a target in the treatment of ALD and a potential prognostic marker for disease progression.

[1]  C. Hellerbrand,et al.  Identification of cytochrome CYP2E1 as critical mediator of synergistic effects of alcohol and cellular lipid accumulation in hepatocytes in vitro , 2015, Oncotarget.

[2]  H. Bartsch,et al.  The role of reactive oxygen species (ROS) and cytochrome P-450 2E1 in the generation of carcinogenic etheno-DNA adducts , 2014, Redox biology.

[3]  N. Nieto,et al.  CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease. , 2013, Journal of hepatology.

[4]  T. Arisawa,et al.  Chronic Ingestion of Ethanol Induces Hepatocellular Carcinoma in Mice Without Additional Hepatic Insult , 2013, Digestive Diseases and Sciences.

[5]  S. Friedman,et al.  Fibrosis‐dependent mechanisms of hepatocarcinogenesis , 2012, Hepatology.

[6]  T. Roskams,et al.  EASL clinical practical guidelines: management of alcoholic liver disease. , 2012, Journal of hepatology.

[7]  Xiang‐Dong Wang,et al.  Cytochrome P450 2E1 inhibition prevents hepatic carcinogenesis induced by diethylnitrosamine in alcohol-fed rats. , 2012, Hepatobiliary surgery and nutrition.

[8]  Chun Liu,et al.  Long-term ethanol consumption promotes hepatic tumorigenesis but impairs normal hepatocyte proliferation in rats. , 2011, The Journal of nutrition.

[9]  K. Mann,et al.  Identifying the gap between need and intervention for alcohol use disorders in Europe. , 2011, Addiction.

[10]  H. Bartsch,et al.  Ethanol‐mediated carcinogenesis in the human esophagus implicates CYP2E1 induction and the generation of carcinogenic DNA‐lesions , 2011, International journal of cancer.

[11]  Defeng Wu,et al.  Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice. , 2010, Free radical biology & medicine.

[12]  H. Bartsch,et al.  Ethanol‐induced cytochrome P4502E1 causes carcinogenic etheno‐DNA lesions in alcoholic liver disease , 2009, Hepatology.

[13]  M. Ingelman-Sundberg,et al.  The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model. , 2009, Journal of hepatology.

[14]  A. Cederbaum,et al.  Cytochrome P450 2E1 contributes to ethanol‐induced fatty liver in mice , 2008, Hepatology.

[15]  Defeng Wu,et al.  Cytochrome P4502E1 sensitizes to tumor necrosis factor alpha–induced liver injury through activation of mitogen‐activated protein kinases in mice , 2008, Hepatology.

[16]  F. Stickel,et al.  “Allgemeine und systematische Pharmakologie und Toxikologie” WS 18/19 Seminarthema: Chemische Kanzerogenese , 2017 .

[17]  J. Sicklick,et al.  Sustained activation of Rac1 in hepatic stellate cells promotes liver injury and fibrosis in mice , 2006, Hepatology.

[18]  A. Cederbaum,et al.  Enhancement by pyrazole of lipopolysaccharide‐induced liver injury in mice: Role of cytochrome P450 2E1 and 2A5 , 2006, Hepatology.

[19]  D. Albertson,et al.  Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability , 2005, Nature.

[20]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[21]  I. Rusyn,et al.  Cytochrome P450 CYP2E1, but not nicotinamide adenine dinucleotide phosphate oxidase, is required for ethanol‐induced oxidative DNA damage in rodent liver , 2005, Hepatology.

[22]  H. Bartsch,et al.  Immunohistochemical detection of 1,N6-ethenodeoxyadenosine in nuclei of human liver affected by diseases predisposing to hepato-carcinogenesis. , 2004, Carcinogenesis.

[23]  M. Tang,et al.  The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma. , 2002, Carcinogenesis.

[24]  S. French,et al.  Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage , 2002, Hepatology.

[25]  S. Friedman,et al.  Cytochrome P450 2E1-derived Reactive Oxygen Species Mediate Paracrine Stimulation of Collagen I Protein Synthesis by Hepatic Stellate Cells* , 2002, The Journal of Biological Chemistry.

[26]  E. Albano.  Free radical mechanisms in immune reactions associated with alcoholic liver disease. , 2002, Free radical biology & medicine.

[27]  S. Friedman,et al.  Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1–derived reactive oxygen species , 2002, Hepatology.

[28]  A. Grollman,et al.  Mutagenesis induced by a single 1,N6-ethenodeoxyadenosine adduct in human cells. , 2000, Cancer research.

[29]  A. Barbin.  Etheno-adduct-forming chemicals: from mutagenicity testing to tumor mutation spectra. , 2000, Mutation research.

[30]  H. Bartsch,et al.  Immunohistochemical detection of 1,N(6)-ethenodeoxyadenosine, a promutagenic DNA adduct, in liver of rats exposed to vinyl chloride or an iron overload. , 2000, Carcinogenesis.

[31]  M. Ingelman-Sundberg,et al.  Inhibition of Ethanol-Induced Liver Disease in the Intragastric Feeding Rat Model by Chlormethiazole (44545) , 2000 .

[32]  H. Seitz,et al.  Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans , 1997, Hepatology.

[33]  G. Pandya,et al.  1,N6-ethenodeoxyadenosine, a DNA adduct highly mutagenic in mammalian cells. , 1996, Biochemistry.

[34]  H. Bartsch,et al.  Formation of 1,N6-ethenoadenine and 3,N4-ethenocytosine by lipid peroxidation products and nucleic acid bases. , 1995, Chemical research in toxicology.

[35]  J. Essigmann,et al.  Mutagenic and genotoxic effects of three vinyl chloride-induced DNA lesions: 1,N6-ethenoadenine, 3,N4-ethenocytosine, and 4-amino-5-(imidazol-2-yl)imidazole. , 1993, Biochemistry.

[36]  H. Bartsch,et al.  Etheno adducts formed in DNA of vinyl chloride-exposed rats are highly persistent in liver. , 1992, Carcinogenesis.

[37]  L. Loeb,et al.  The vinyl chloride DNA derivative N2,3-ethenoguanine produces G----A transitions in Escherichia coli. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. Rosman,et al.  The intralobular distribution of ethanol‐inducible P450IIE1 in rat and human liver , 1989, Hepatology.

[39]  M. Harms-Ringdahl,et al.  Interaction of lipid peroxidation products with DNA. A review. , 1988, Mutation research.

[40]  F. Chung,et al.  1,N2-ethenodeoxyguanosine as a potential marker for DNA adduct formation by trans-4-hydroxy-2-nonenal. , 1988, Cancer research.

[41]  W. Haddon,et al.  Formation of cyclic adducts of deoxyguanosine with the aldehydes trans-4-hydroxy-2-hexenal and trans-4-hydroxy-2-nonenal in vitro. , 1986, Cancer research.

[42]  J. Miller,et al.  The metabolic activation and nucleic acid adducts of naturally-occurring carcinogens: recent results with ethyl carbamate and the spice flavors safrole and estragole. , 1983, British Journal of Cancer.

[43]  S. French.  The importance of CYP2E1 in the pathogenesis of alcoholic liver disease and drug toxicity and the role of the proteasome. , 2013, Sub-cellular biochemistry.

[44]  Xiang‐Dong Wang,et al.  The role of cytochrome P450 2E1 in ethanol-mediated carcinogenesis. , 2013, Sub-cellular biochemistry.

[45]  C. Lieber.  CYP2E1: from ASH to NASH. , 2004, Hepatology research : the official journal of the Japan Society of Hepatology.

[46]  A. Rosman,et al.  Dynamics of cytochrome P4502E1 activity in man: induction by ethanol and disappearance during withdrawal phase. , 2002, Journal of hepatology.

[47]  H. Bartsch,et al.  Formation, detection, and role in carcinogenesis of ethenobases in DNA. , 1994, Drug metabolism reviews.

[48]  F. Chung,et al.  Stereoselective formation of in vitro nucleic acid adducts by 2,3-epoxy-4-hydroxynonanal. , 1991, Cancer research.

[49]  W. Pryor,et al.  Suggested mechanisms for the production of 4-hydroxy-2-nonenal from the autoxidation of polyunsaturated fatty acids. , 1990, Free radical biology & medicine.

[50]  F. Chung,et al.  Structural characterization of adducts formed in the reaction of 2,3-epoxy-4-hydroxynonanal with deoxyguanosine. , 1989, Chemical research in toxicology.

[51]  H. Bartsch,et al.  1,N6-etheno-2'-deoxyadenosine and 3,N4-etheno-2'-deoxycytidine detected by monoclonal antibodies in lung and liver DNA of rats exposed to vinyl chloride. , 1989, Carcinogenesis.